US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

Core Insights - The U.S. Centers for Medicare & Medicaid Services has announced a new group of branded drugs from major pharmaceutical companies for the third cycle of the Medicare Drug Price Negotiation program [1] Company Insights - Major pharmaceutical companies involved include Eli Lilly, Pfizer, and AbbVie, indicating their significant role in the Medicare Drug Price Negotiation program [1]